Achieve Life Sciences (ACHV) Assets (2010 - 2026)

Achieve Life Sciences has disclosed Assets across 17 years of filings, most recently posting $33.1 million for Q1 2026.

• Quarterly Assets rose 21.01% year-over-year to $33.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $33.1 million (up 21.01% YoY) and the FY2025 annual result came in at $41.8 million, up 8.17% from the prior year.
• Assets eased to $33.1 million in Q1 2026, from $41.8 million in the prior quarter.
• Over five years, Assets peaked at $70.0 million in Q1 2024 and troughed at $19.4 million in Q4 2023.
• A 5-year average of $38.6 million and a median of $34.0 million in 2022 frame the typical range for Assets.
• Annual changes were most pronounced in 2024 — Assets jumped 236.71% — and 2025, when it plunged 60.93%.
• Tracing ACHV's Assets over 5 years: stood at $30.0 million in 2022, then tumbled by 35.37% to $19.4 million in 2023, then surged by 99.44% to $38.6 million in 2024, then grew by 8.17% to $41.8 million in 2025, then decreased by 20.78% to $33.1 million in 2026.
• Business Quant data shows ACHV's Assets at $33.1 million in Q1 2026, $41.8 million in Q4 2025, and $52.0 million in Q3 2025.